| Tumor invasion as dysregulated cell motility J Kassis, DA Lauffenburger, T Turner, A Wells Seminars in cancer biology 11 (2), 105-117, 2001 | 224 | 2001 |
| Growth factor-induced cell motility in tumor invasion A Wells, J Kassis, J Solava, T Turner, DA Lauffenburger Acta Oncologica 41 (2), 124-130, 2002 | 179 | 2002 |
| A role for phospholipase C-γ-mediated signaling in tumor cell invasion J Kassis, J Moellinger, H Lo, NM Greenberg, HG Kim, A Wells Clinical cancer research 5 (8), 2251-2260, 1999 | 156 | 1999 |
| Epidermal growth factor receptor-stimulated activation of phospholipase Cγ-1 promotes invasion of head and neck squamous cell carcinoma SM Thomas, FM Coppelli, A Wells, WE Gooding, J Song, J Kassis, ... Cancer research 63 (17), 5629-5635, 2003 | 151 | 2003 |
| Invited Reviews-EGF receptor signaling in prostate morphogenesis and tumorigenesis HG Kim, J Kassis, JC Souto, T Turner, A Wells Histology and histopathology 14 (4), 1175-1182, 1999 | 140 | 1999 |
| 3D in vitro tissue models and their potential for drug screening L Kimlin, J Kassis, V Virador Expert opinion on drug discovery 8 (12), 1455-1466, 2013 | 96 | 2013 |
| Molecular inhibition of phospholipase cgamma signaling abrogates DU-145 prostate tumor cell invasion. T Turner, MV Epps-Fung, J Kassis, A Wells Clinical cancer research: an official journal of the American Association …, 1997 | 83 | 1997 |
| CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins JN Kassis, EA Guancial, H Doong, V Virador, EC Kohn Experimental cell research 312 (15), 2962-2971, 2006 | 82 | 2006 |
| Calcium as a molecular target in angiogenesis AM Patton, J Kassis, H Doong, EC Kohn Current pharmaceutical design 9 (7), 543-551, 2003 | 80 | 2003 |
| PLCγ contributes to metastasis of in situ-occurring mammary and prostate tumors CR Shepard, J Kassis, DL Whaley, HG Kim, A Wells Oncogene 26 (21), 3020-3026, 2007 | 73 | 2007 |
| Tumor microenvironment: what can effusions teach us? J Kassis, J Klominek, EC Kohn Diagnostic cytopathology 33 (5), 316-319, 2005 | 70 | 2005 |
| DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling A Mamoune, J Kassis, S Kharait, S Kloeker, E Manos, DA Jones, A Wells Experimental cell research 299 (1), 91-100, 2004 | 65 | 2004 |
| Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activity OC Attucks, KJ Jasmer, M Hannink, J Kassis, Z Zhong, S Gupta, ... PLoS One 9 (7), e101044, 2014 | 63 | 2014 |
| Physics of bioprinting A Shafiee, E Ghadiri, H Ramesh, C Kengla, J Kassis, P Calvert, ... Applied Physics Reviews 6 (2), 2019 | 50 | 2019 |
| EBV‐expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness J Kassis, A Maeda, N Teramoto, K Takada, C Wu, G Klein, A Wells International journal of cancer 99 (5), 644-651, 2002 | 45 | 2002 |
| Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling A Wells, JCS Souto, J Solava, J Kassis, KJ Bailey, T Turner Clinical cancer research 8 (4), 1251-1257, 2002 | 41 | 2002 |
| Motility is rate-limiting for invasion of bladder carcinoma cell lines J Kassis, R Radinsky, A Wells The International Journal of Biochemistry & Cell Biology 34 (7), 762-775, 2002 | 40 | 2002 |
| The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome VM Virador, B Davidson, J Czechowicz, A Mai, J Kassis, EC Kohn PLoS One 4 (4), e5136, 2009 | 39 | 2009 |
| Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3—modulated adhesion and invasion JN Kassis, VM Virador, EA Guancial, D Kimm, AS Ho, M Mishra, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 38 | 2009 |
| Biosensing technologies for medical applications, manufacturing, and regenerative medicine A Shafiee, E Ghadiri, J Kassis, N Pourhabibi Zarandi, A Atala Current Stem Cell Reports 4, 105-115, 2018 | 35 | 2018 |
